SYMBOTIC INC. (SYM) Spending and interest coverage
- R&D / revenue · 12 months: Value 7.68%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-27..
- Stock-based compensation / revenue · 12 months: Value 8.86%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-27..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-27; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 7.68% | Research and development expense / revenue. Period ending 2026-06-27. $203.12M ÷ $2.65B × 100 ≈ 7.68% |
| Stock-based compensation / revenue · 12 months | 8.86% | Share-based compensation / revenue. Period ending 2026-06-27. $234.53M ÷ $2.65B × 100 ≈ 8.86% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 203.12M USD | Research and Development Expense |
| Revenue | 2.65B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 234.53M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -250.00K USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $203.12M | $2.65B | $234.53M | $-250.00K | (m) | 7.68% | 8.86% | (m) | (m) |
| 2026-03-28 | $209.06M | $2.52B | $222.90M | $-58.95M | (m) | 8.31% | 8.86% | (m) | (m) |
| 2025-12-27 | $215.74M | $2.39B | $205.27M | $-85.51M | (m) | 9.03% | 8.59% | (m) | (m) |
| 2025-09-27 | $216.01M | $2.25B | $183.94M | $-115.01M | (m) | 9.61% | 8.19% | (m) | (m) |
| 2025-06-28 | $197.41M | $2.19B | $144.92M | $-82.36M | (m) | 9.00% | 6.61% | (m) | (m) |
| 2025-03-29 | $189.98M | $2.07B | $124.81M | $-83.42M | (m) | 9.17% | 6.03% | (m) | (m) |
| 2024-12-28 | $174.91M | $1.91B | $109.52M | $-116.25M | (m) | 9.13% | 5.72% | (m) | (m) |
| 2024-09-28 | $173.46M | $1.79B | $112.21M | $-116.72M | (m) | 9.70% | 6.27% | (m) | (m) |
| 2024-06-29 | $179.12M | $1.68B | $119.32M | $-149.12M | (m) | 10.68% | 7.12% | (m) | (m) |
| 2024-03-30 | $183.24M | $1.50B | $126.99M | $-165.94M | (m) | 12.24% | 8.49% | (m) | (m) |
| 2023-12-30 | $186.45M | $1.34B | $134.15M | $-172.71M | (m) | 13.92% | 10.02% | (m) | (m) |
| 2023-09-30 | $195.04M | $1.18B | $154.23M | $-223.23M | (m) | 16.57% | 13.10% | (m) | (m) |
| 2023-06-24 | $192.71M | $1.03B | $148.57M | $-223.60M | (m) | 18.72% | 14.43% | (m) | (m) |
| 2023-03-25 | $179.01M | $893.13M | $111.57M | $-214.63M | (m) | 20.04% | 12.49% | (m) | (m) |
| 2022-12-24 | $152.70M | $722.56M | $76.37M | $-186.87M | (m) | 21.13% | 10.57% | (m) | (m) |
| 2022-09-24 | $124.14M | $593.31M | $26.86M | $-140.38M | (m) | 20.92% | 4.53% | (m) | (m) |
| 2022-06-25 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | $-8.30M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | $-6.49M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-25 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-25 | $73.39M | $251.91M | $97.00K | $-122.38M | (m) | 29.13% | 0.04% | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-26 | $55.86M | $92.09M | $71.00K | $-110.38M | (m) | 60.66% | 0.08% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.